NCT00785811终止4 期
Randomized, Double Blind, Placebo Controlled Study of Parallel Groups to Evaluate the Effect of Chronic Supplementation of L-arginine in the Muscular Performance.
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 发起方
- Sanofi
- 入组人数
- 36
- 试验地点
- 1
- 主要终点
- Fatigue Resistance Factor (FRF)
研究概览
简要总结
The primary purpose of this study is to evaluate the effect of oral administration of L-arginine in the muscular fatigue of the quadriceps, expressed in terms of the Fatigue Resistance Factor (FRF). The secondary purpose of this study is to evaluate the effect of oral administration of L-arginine in the muscular force the quadriceps.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 20 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
1
Experimental
L-arginine aspartate (Targifor)
干预措施: L-arginine aspartate (Targifor) (Drug)
2
Placebo Comparator
Placebo
干预措施: Placebo L-arginine aspartate (Targifor) (Drug)
结局指标
主要结局
Fatigue Resistance Factor (FRF)
时间窗: Throughout the study
次要结局
- Maximum force in Newton (N) and fast or explosive force(at time 90% of the maximum isometric force)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma MultiformeGlioblastoma MultiformeNCT02017249Inova Health Care Services1
已完成
4 期
L-Arginine and Erectile DysfunctionErectile DysfunctionNCT00777075Hannover Medical School57
已完成
不适用
The Effect of L-arginine in the treatment of Sickle Cell AnemiaD57.1C15.378.071.141.150.150sickle cell anemiaRBR-2t56nzniversidade Federal do Ceará
已完成
2 期
Arginine Therapy for Sickle Cell Disease PainVaso-occlusive Pain EpisodeSickle Cell DiseaseNCT02536170Emory University108
尚未招募
3 期
The effect of L-arginine in non-alcoholic fatty liverIRCT20230409057859N1Shahid Beheshti University of Medical Sciences60